/PETV
PETV Stock - PetVivo Holdings, Inc.
Healthcare|Medical - DevicesOTC
$1.16-4.92%
$0.06 (-4.92%) • Dec 19
63
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.66
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.61
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.28
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PETV
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.15 – $1.17
TARGET (TP)$1.33
STOP LOSS$1.07
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.49
52W High$1.69
52W Low$0.45
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.13M | $968,706 | $917,162 | $115,586 | $12,578 |
| Gross Profit | $994,856 | $739,526 | $390,345 | $-85,568 | $1,883 |
| Gross Margin | 87.8% | 76.3% | 42.6% | -74.0% | 15.0% |
| Operating Income | $-8,055,720 | $-10,621,340 | $-8,733,452 | $-5,056,528 | $-1,958,988 |
| Net Income | $-8,399,166 | $-10,955,295 | $-8,701,764 | $-4,941,782 | $-3,751,375 |
| Net Margin | -741.6% | -1130.9% | -948.8% | -4275.4% | -29824.9% |
| EPS | $-0.41 | $-0.78 | $-0.85 | $-0.56 | $-0.61 |
Company Overview
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PETVBeat Rate
29%
Last 7 quarters
Avg Surprise
-11.2%
EPS vs Estimate
Beats / Misses
2/3
2 met exactly
Latest EPS
$-0.11
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 12, 2026 | — | — | — | — |
Q4 2025 | Nov 14, 2025 | — | $-0.11 | — | — |
Q3 2025 | Aug 14, 2025 | — | $-0.09 | — | — |
Q2 2025 | Jun 30, 2025 | — | $-0.12 | — | — |
Q1 2025 | Feb 14, 2025 | — | $-0.09 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-0.11 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-0.11 | — | — |
Q2 2024 | Jun 28, 2024 | — | $-0.14 | — | — |
Q1 2024 | Feb 12, 2024 | — | $-0.12 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-0.23 | — | — |
Q3 2023 | Aug 10, 2023 | — | $-0.25 | — | — |
Q2 2023 | Jun 29, 2023 | $-0.21 | $-0.21 | 0.0% | = MET |
Q1 2023 | Feb 9, 2023 | $-0.23 | $-0.23 | 0.0% | = MET |
Q4 2022 | Nov 10, 2022 | $-0.25 | $-0.21 | +16.0% | ✓ BEAT |
Q3 2022 | Aug 11, 2022 | $-0.23 | $-0.20 | +13.0% | ✓ BEAT |
Q2 2022 | Jun 29, 2022 | $-0.19 | $-0.25 | -31.6% | ✗ MISS |
Q1 2022 | Feb 10, 2022 | $-0.15 | $-0.17 | -13.3% | ✗ MISS |
Q4 2021 | Nov 15, 2021 | $-0.08 | $-0.13 | -62.5% | ✗ MISS |
Q3 2021 | Aug 16, 2021 | — | $-0.07 | — | — |
Q3 2021 | Aug 13, 2021 | — | $-0.05 | — | — |
Frequently Asked Questions about PETV
What is PETV's current stock price?
PetVivo Holdings, Inc. (PETV) is currently trading at $1.16 per share. The stock has moved -4.92% today.
What is the analyst price target for PETV?
No analyst price targets are currently available for this stock.
What sector is PetVivo Holdings, Inc. in?
PetVivo Holdings, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is PETV's market cap?
PetVivo Holdings, Inc. has a market capitalization of $0.03 billion, making it a small-cap company.
Does PETV pay dividends?
No, PetVivo Holdings, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAHGIF
Alternate Health Corp.
$0.00
Mkt Cap: $0.0B
CLIFF
Cordlife Group Limited
$0.10
Mkt Cap: $0.0B
ELXMF
Nova Eye Medical Limited
$0.00
Mkt Cap: $0.0B
EOFBF
Ecofibre Limited
$0.00
Mkt Cap: $0.0B
EXHI
Exlites Holdings International, Inc.
$0.17
Mkt Cap: $0.0B
IPDQF
ImpediMed Limited
$0.02
Mkt Cap: $0.0B
NVYTF
Novacyt S.A.
$0.51
Mkt Cap: $0.0B
NXSCF
Next Science Limited
$0.08
Mkt Cap: $0.0B
POSC
Positron Corporation
$1.55
Mkt Cap: $0.0B
PVCT
Provectus Biopharmaceuticals, Inc.
$0.06
Mkt Cap: $0.0B
Explore stocks similar to PETV for comparison